PM
The startup develops a trans-catheter mitral valve system that replaces the posterior leaflet with a prosthetic leaflet, enabling hemi-replacements of the mitral valve. This technology addresses mitral regurgitation by enhancing coaptation with the native anterior leaflet, improving patient outcomes.
Updated 3 months ago
Funding
$65M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a trans-catheter mitral valve system that replaces the posterior leaflet with a prosthetic leaflet, enabling hemi-replacements of the mitral valve. This technology addresses mitral regurgitation by enhancing coaptation with the native anterior leaflet, improving patient outcomes.